Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3188634 | Annales de Dermatologie et de Vénéréologie | 2009 | 5 Pages |
Abstract
The worsening experienced by our patient 1 week after the beginning of the treatment is comparable with the immune reconstitution syndrome occasionally observed in tuberculosis in immunocompromised hosts, thus raising the question of the potential value of continuing infliximab treatment. Recommendations are needed concerning the prevention and treatment of M. marinum infections in patients on anti-TNFα biotherapies.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
A. Guyot, E. Begon, L. Abramowitz, J. Landry, E. Marinho, V. Descamps, B. Crickx,